Madopark Quick

Levodopa / Benserazide, the active ingredient in Madopark Quick, is a dopamine precursor with dopa decarboxylase inhibitor presented as an immediate‑release oral tablet for oral use. It treats Parkinson's disease in adults.

GNH USA supplies Madopark Quick as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Madopark Quick is indicated for the management of Parkinsonian disorders by restoring central dopamine levels.

- Parkinson's disease: Improves motor symptoms and functional ability in patients with idiopathic Parkinson's disease. - Motor fluctuations in Parkinson's disease: Reduces OFF periods and increases ON time without troublesome dyskinesia. - Drug‑induced parkinsonism: Provides symptomatic relief when anticholinergic therapy is insufficient.

Common Side Effects: - Nausea: Upset stomach or feeling sick. - Orthostatic hypotension: Dizziness upon standing. - Headache: Mild to moderate head pain. - Insomnia: Difficulty falling or staying asleep. - Dyskinesia: Involuntary movements, especially at higher doses. - Dry mouth: Reduced salivation.

Serious or Rare Side Effects: - Severe hypotension: Marked drop in blood pressure requiring medical attention. - Psychosis or hallucinations: Visual or auditory disturbances. - Neuroleptic malignant syndrome: Rare but life‑threatening reaction. - Cardiac arrhythmias: Irregular heart rhythms. - Severe allergic reactions: Rash, swelling, or breathing difficulty.

When prescribing Madopark Quick, clinicians should consider several safety measures. - Dose titration: Start with a low dose and increase gradually to minimize side effects. - Blood pressure monitoring: Watch for orthostatic hypotension, especially in the elderly. - Psychiatric assessment: Monitor for hallucinations, confusion, or mood changes. - Contraindications: Avoid in patients with narrow‑angle glaucoma or those taking non‑selective MAO inhibitors. - Renal/hepatic impairment: Adjust dosing based on organ function. - Store at ambient temperature: Keep in the original pack, protect from moisture.

Madopark Quick may interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: Risk of hypertensive crisis. - Antipsychotics (dopamine antagonists): Reduce therapeutic effect. - High‑dose pyridoxine (vitamin B6): Decreases levodopa availability.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: May enhance blood‑pressure‑lowering effect. - SSRIs or other serotonergic drugs: Potential for serotonin syndrome. - Other dopaminergic agents: May increase risk of dyskinesia.